1 |
CELGENE CORPORATION v. EMCURE PHARMACEUTICALS LTD. et al |
3:18-cv-11218 |
D.N.J. |
|
|
|
|
2 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
3 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
4 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
5 |
Sanofi-Aventis U.S. LLC et al v. Emcure Pharmaceuticals Ltd. et al |
1:16-cv-01330 |
D.Del. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
6 |
Fresenius Kabi USA, LLC v. Emcure Pharmaceuticals USA Inc. et al |
1:14-cv-01141 |
D.Del. |
|
|
|
|
7 |
ASTELLAS US LLC et al v. EMCURE PHARMACEUTICALS USA, INC. et al |
2:14-cv-01665 |
D.N.J. |
|
|
|
|
8 |
ASTELLAS US LLC et al v. EMCURE PHARMACEUTICALS USA, INC. et al |
2:14-cv-01665 |
D.N.J. |
|
|
|
|
9 |
ASTELLAS US LLC et al v. EMCURE PHARMACEUTICALS USA, INC. et al |
2:14-cv-01665 |
D.N.J. |
|
|
|
|